KP Tissue Statistics
Total Valuation
KP Tissue has a market cap or net worth of 81.19 million.
Market Cap | 81.19M |
Enterprise Value | n/a |
Important Dates
The next estimated earnings date is Thursday, August 8, 2024.
Earnings Date | Aug 8, 2024 |
Ex-Dividend Date | Jun 28, 2024 |
Share Statistics
KP Tissue has 9.97 million shares outstanding. The number of shares has increased by 0.18% in one year.
Shares Outstanding | 9.97M |
Shares Change (YoY) | +0.18% |
Shares Change (QoQ) | +0.05% |
Owned by Insiders (%) | 0.14% |
Owned by Institutions (%) | 8.61% |
Float | 9.93M |
Valuation Ratios
The trailing PE ratio is 11.97 and the forward PE ratio is 17.76. KP Tissue's PEG ratio is 1.44.
PE Ratio | 11.97 |
Forward PE | 17.76 |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 1.15 |
P/FCF Ratio | 11.81 |
PEG Ratio | 1.44 |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.02
Current Ratio | 1.02 |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 9.72% and return on invested capital (ROIC) is 22.91%.
Return on Equity (ROE) | 9.72% |
Return on Assets (ROA) | 9.41% |
Return on Capital (ROIC) | 22.91% |
Revenue Per Employee | n/a |
Profits Per Employee | 2,545 |
Employee Count | 2,700 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | -67.00M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -22.51% in the last 52 weeks. The beta is 0.40, so KP Tissue's price volatility has been lower than the market average.
Beta (1Y) | 0.40 |
52-Week Price Change | -22.51% |
50-Day Moving Average | 8.39 |
200-Day Moving Average | 9.09 |
Relative Strength Index (RSI) | 40.76 |
Average Volume (30 Days) | 21,328 |
Short Selling Information
The latest short interest is 269,784, so 2.70% of the outstanding shares have been sold short.
Short Interest | 269,784 |
Short Previous Month | 273,698 |
Short % of Shares Out | 2.70% |
Short % of Float | 2.72% |
Short Ratio (days to cover) | 24.32 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | 1.16M |
Pretax Income | 5.15M |
Net Income | 6.87M |
EBITDA | -1.02M |
EBIT | -60.13M |
Earnings Per Share (EPS) | 0.69 |
Balance Sheet
Cash & Cash Equivalents | n/a |
Total Debt | n/a |
Net Cash | n/a |
Net Cash Per Share | n/a |
Equity / Book Value | 70.72M |
Book Value Per Share | 7.09 |
Working Capital | 56,000 |
Cash Flow
Operating Cash Flow | 6.87M |
Capital Expenditures | n/a |
Free Cash Flow | 6.87M |
FCF Per Share | 0.69 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.72, which amounts to a dividend yield of 8.85%.
Dividend Per Share | 0.72 |
Dividend Yield | 8.85% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 104.35% |
Buyback Yield | -0.18% |
Shareholder Yield | 8.67% |
Earnings Yield | 8.46% |
FCF Yield | 8.47% |
Analyst Forecast
Price Target | 9.13 |
Price Target Difference | 12.16% |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |